Related Experiment Video
Updated: Jun 9, 2025

A Fluorogenic Peptide Cleavage Assay to Screen for Proteolytic Activity: Applications for coronavirus spike protein activation
Published on: January 9, 2019
Acquisition of a multibasic cleavage site does not increase MERS-CoV entry into Calu-3 human lung cells
Markus Hoffmann1,2, Hannah Kleine-Weber1,2, Luise Graichen1
1Infection Biology Unit, German Primate Center- Leibniz Institute for Primate Research, Göttingen, Germany.
Abstract:
Human-to-human transmission of the highly pathogenic Middle East respiratory syndrome coronavirus (MERS-CoV) is currently inefficient. However, there is concern that the virus might mutate and thereby increase its transmissibility and thus pandemic potential. The pandemic SARS-CoV-2 depends on a highly cleavable furin motif at the S1/S2 site of the viral spike (S) protein for efficient lung cell entry, transmission, and pathogenicity. Here, by employing pseudotyped particles, we investigated whether augmented cleavage at the S1/S2 site also increases MERS-CoV entry into Calu-3 human lung cells. We report that polymorphism T746K at the S1/S2 cleavage site or optimization of the furin motif increases S protein cleavage but not lung cell entry. These findings suggest that, unlike what has been reported for SARS-CoV-2, a highly cleavable S1/S2 site might not augment MERS-CoV infectivity for human lung cells.IMPORTANCEThe highly cleavable furin motif in the spike protein is required for robust lung cell entry, transmission, and pathogenicity of SARS-CoV-2. In contrast, it is unknown whether optimization of the furin motif in the spike protein of the pre-pandemic MERS-CoV increases lung cell entry and allows for robust human-human transmission. The present study indicates that this might not be the case. Thus, neither a naturally occurring polymorphism that increased MERS-CoV spike protein cleavage nor artificial optimization of the cleavage site allowed for increased spike-protein-driven entry into Calu-3 human lung cells.
Insights
Augmenting the MERS-CoV spike protein cleavage site does not enhance lung cell entry. This suggests MERS-CoV may not increase human-to-human transmission through mutations in its spike protein.
Area of Science:
- Virology
- Infectious Diseases
- Molecular Biology
Background:
- Human-to-human transmission of Middle East respiratory syndrome coronavirus (MERS-CoV) is inefficient.
- The SARS-CoV-2 pandemic virus utilizes a highly cleavable furin motif for efficient cell entry and pathogenicity.
- Concerns exist regarding MERS-CoV's potential to mutate for increased transmissibility.
Purpose of the Study:
- To investigate if enhanced cleavage at the MERS-CoV spike protein's S1/S2 site increases entry into human lung cells.
- To determine if MERS-CoV's pandemic potential can be augmented through spike protein mutations.
Main Methods:
- Utilized pseudotyped particles to model MERS-CoV infection.
- Investigated the impact of a T746K polymorphism and furin motif optimization on MERS-CoV spike protein cleavage.
- Assessed MERS-CoV entry into Calu-3 human lung cells.
Main Results:
- A T746K polymorphism and furin motif optimization increased MERS-CoV spike protein cleavage.
- Neither modification significantly enhanced MERS-CoV entry into Calu-3 human lung cells.
- Findings contrast with the role of the furin motif in SARS-CoV-2 infectivity.
Conclusions:
- A highly cleavable S1/S2 site may not enhance MERS-CoV infectivity in human lung cells.
- Spike protein cleavage augmentation does not appear to increase MERS-CoV's potential for robust human-to-human transmission.
- MERS-CoV may differ from SARS-CoV-2 in its dependence on spike protein cleavage for cell entry and transmission.
More Related Videos
10:21Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
Published on: January 5, 2018
08:40Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019